Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Feature Stories

Latest Feature Stories

Hani Tah Suleyman, 63 years old, in his room during a psychological support session, in MSF’s post-operative care facility in East Mosul. Photograph by Candida Lobes

Hani Tah Suleyman, 63 years old, in his room during a psychological support session, in MSF’s post-operative care facility in East Mosul. Photograph by Candida Lobes.

Feature story
Feature story |
24 January 2019
Antimicrobial resistance
Iraq

Iraq: Antibiotic resistance in Mosul

6 min
Our wishes for 2019 banner
Feature story
Feature story |
01 January 2019

Our wishlist for 2019

3 min
Abdul Wahab, 32, resident of Muslimbagh, leaves MSF CL Facility in Kuchlack, Quetta, after getting his treatment for his sand fly bite. Photograph by Khaula Jamil
Feature story
Feature story |
05 December 2018
Tropical & neglected diseases
Pakistan

Bringing hope to sufferers of a neglected disease

5 min
Health workers are seen writing their names on their personal protective equipment (PPE) before entering the red zone of a MSF supported Ebola Treatment Centre(ETC), where the will be checking up on patients on November 03, 2018 in Butembo. Photograph by John Wessels
Feature story
Feature story |
03 December 2018
Tropical & neglected diseases
Democratic Republic of the Congo

Ebola spreads further into urban communities and isolated areas in North Kivu

4 min
Olena Melnikova, 42-years-old, taking a viral load test in the process of hepatitis C treatment. She is one of the patients who underwent the hepatitis C treatment provided by MSF in Mykolaiv. Photograph by Aleksandr Glyadyelov
Feature story
Feature story |
01 December 2018
Hepatitis C HIV/AIDS
Ukraine

HIV-hepatitis C co-infection in Mykolaiv, Ukraine

7 min
South Africa has one of the highest burdens of TB and (Drug Resistant) DR-TB in the world, with around 20,000 people diagnosed with DR-TB in 2015. In Khayelitsha, Western Cape, which has some of the country’s highest rates of DR-TB, MSF runs a strengthened regimen programme that incorporates new drugs into treatment regimens for DR-TB patients including Delamanid and Bedaquiline. Photograph by Sydelle Willow Smith
Feature story
Feature story |
28 September 2018
Tuberculosis
South Africa

The Story of Goodman Mkhanda

Zoya, who has been treated for kala azar-HIV co-infection and tuberculosis at MSF's ward in Patna, Bihar is one of the many patients navigating the social stigma that is associated with the diseases in the social context of Bihar. Photograph by Vaishnavi Singh
Feature story
Feature story |
24 September 2018
Tropical & neglected diseases
EthiopiaIndia

HIV-kala azar co-infection stories

10 min
The emergence of multi-drug resistant (MDR) and extensive drug-resistant (XDR) TB in recent years has seen some patients end up with minimal chances of recovery through medication alone. The relevance of TB surgery has therefore risen again but presents new challenges in high-burden TB countries. Photograph by MSF
Feature story
Feature story |
31 July 2018
Tuberculosis
Armenia

Chronicles of a Surgery, Armenia

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury